Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/27/2013 | US8518700 Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Bmi1 and low molecular weight substance, and method for generating induced pluripotent stem cells using the same |
08/27/2013 | US8518699 Methods for genetic diversification in gene conversion active cells |
08/27/2013 | US8518698 Method of promoting apoptosis of glioblastoma tumor cells |
08/27/2013 | US8518697 Single chain trimers and uses therefor |
08/27/2013 | US8518696 Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection |
08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
08/27/2013 | US8518654 Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect |
08/27/2013 | US8518636 Tangential flow filtration devices and methods for leukocyte enrichment |
08/27/2013 | US8518433 Method of treating an osteochondral defect |
08/27/2013 | US8518420 Enhanced bone cells growth and proliferation on TiO2 nanotubular substrates treated by radio-frequency plasma discharge |
08/27/2013 | US8518409 System for selective cell treatment using ideotypically modulated pharmacoeffectors |
08/27/2013 | US8518408 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection |
08/27/2013 | US8518397 Notch induced natural killer cell generation and therapeutic uses |
08/27/2013 | US8518394 Seakem gold agarose beads comprising islets and coated with agarose |
08/27/2013 | US8518392 Promoter-regulated differentiation-dependent self-deleting cassette |
08/27/2013 | US8518391 Monocytes as a gene delivery vector for secreted proteins to treat Alzheimer'S disease |
08/27/2013 | US8518390 Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
08/27/2013 | CA2828015A1 Megakaryocyte and platelet production from stem cells |
08/27/2013 | CA2642855C Use of fucans for the purposes of bone grafting, engineering and regeneration |
08/27/2013 | CA2543977C Use of particulate labels in bioanalyte detection methods |
08/27/2013 | CA2486918C Novel chimeric cd154 |
08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
08/27/2013 | CA2400441C Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
08/22/2013 | WO2013123365A1 Transgenic animals with customizable traits |
08/22/2013 | WO2013123292A1 Phenotype profile of human retinal progenitor cells |
08/22/2013 | WO2013123217A1 Small molecules that enhance the activity of oligonucleotides |
08/22/2013 | WO2013123214A1 Methods and composition related to brown adipose-like cells |
08/22/2013 | WO2013123151A1 Methods of controlling tumor bioenergetics networks |
08/22/2013 | WO2013123084A1 Method for detecting circulating fetal cells |
08/22/2013 | WO2013123051A1 Method for modulating the number of archesporial cells in a developing anther |
08/22/2013 | WO2013122950A1 Nprcps, pfdncs and uses thereof |
08/22/2013 | WO2013122864A1 Feeder-free method for culture of bovine and porcine spermatogonial stem cells |
08/22/2013 | WO2013121427A1 Mesenchymal stem cells conditioned medium and methods of generating and using the same |
08/22/2013 | WO2013121426A1 Culturing of mesenchymal stem cells |
08/22/2013 | WO2013121194A1 Materials and methods relating to packaging cell lines |
08/22/2013 | WO2013120973A1 Method of producing high-affinity antibodies |
08/22/2013 | WO2013120959A1 Angiostatin chimeras and uses thereof |
08/22/2013 | WO2013090585A3 Methods and compositions for analyzing ahasl genes in wheat |
08/22/2013 | WO2013089819A3 Microrna mediated neuronal cell induction |
08/22/2013 | WO2013086419A8 Polymer scaffolds and their use in the treatment of vision loss |
08/22/2013 | US20130219555 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants |
08/22/2013 | US20130219551 Maize Inbred PH1DAY |
08/22/2013 | US20130219550 Maize Inbred PH1KR5 |
08/22/2013 | US20130219548 Maize Inbred PH1MC3 |
08/22/2013 | US20130219537 Pepper hybrid ps16364528 |
08/22/2013 | US20130217752 Method of deriving mature hepatocytes from human embryonic stem cells |
08/22/2013 | US20130217129 Conditioned cell culture medium compositions and methods of use |
08/22/2013 | US20130217128 Method of manufacturing a tissue-engineered prosthesis |
08/22/2013 | US20130217127 Cryogels of pva-boronic acid containing co-polymers for cell culture |
08/22/2013 | US20130217126 Dried hydrogel, dried vitrigel membrane, and methods for producing the same |
08/22/2013 | US20130217125 Culture method |
08/22/2013 | US20130217123 Method for dental pulp cryopreservation |
08/22/2013 | US20130217122 Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library |
08/22/2013 | US20130217120 Placenta-derived cell-conditioned culture media and animal-free, feeder-free method for culturing stem cells using the same |
08/22/2013 | US20130217119 Modular dna-binding domains and methods of use |
08/22/2013 | US20130217118 Adipose-derived stem cells and lattices |
08/22/2013 | US20130217114 Rapid membrane isolation method for animal and plant samples |
08/22/2013 | US20130217098 Production of isoprenoids |
08/22/2013 | US20130217094 Enzyme solution for separating cell, method for separating cell and method for separating pancreatic islet |
08/22/2013 | US20130217069 Conditioned cell culture medium compositions and methods of use |
08/22/2013 | US20130217014 Methods of using cdk8 antagonists |
08/22/2013 | US20130217005 Generation of anterior foregut endoderm from pluripotent cells |
08/22/2013 | US20130216584 Compositions and methods for producing dendritic cells |
08/22/2013 | US20130216509 Chimeric receptors with 4-1bb stimulatory signaling domain |
08/22/2013 | US20130216508 Human lung stem cells and uses thereof |
08/22/2013 | US20130216507 Methods for promoting hsc engraftment |
08/22/2013 | US20130216506 Bioreactor for Isolation of Rare Cells and Methods of Use |
08/22/2013 | US20130216505 Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses |
08/22/2013 | US20130216503 Methods for Generating Cardiomyocytes |
08/22/2013 | US20130216502 Methods of Treating Intestinal Injury Using Heparin Binding Epidermal Growth Factor and Stem Cells |
08/22/2013 | CA2850380A1 Agents and method for treating inflammation-related conditions and diseases |
08/21/2013 | EP2628797A1 Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain |
08/21/2013 | EP2628791A1 Perfusion module for the co-culture of endothelial cells and smooth muscle cells for determining patho-physiological changes |
08/21/2013 | EP2628752A1 Engineered anti-TSLP antibody |
08/21/2013 | EP2628748A1 Angiostatin chimeras and uses thereof |
08/21/2013 | EP2627779A1 Quality determination of stem cells |
08/21/2013 | EP2627771A1 Methods for altering the reactivity of plant cell walls |
08/21/2013 | EP2627766A2 Methods and compositions for the treatment of insulin-associated medical conditions |
08/21/2013 | EP2627671A1 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
08/21/2013 | EP2627342A2 Cardiac induced pluripotent stem cells and methods of use in repair and regeneration of myocardium |
08/21/2013 | EP2627332A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
08/21/2013 | CN1997732B Culture and use of cells that secrete liver secretory factors |
08/21/2013 | CN1909922B Novel flavivirus antigens |
08/21/2013 | CN103261415A Bioassay method for detecting physiologically active substance |
08/21/2013 | CN103261414A Protein production method |
08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
08/21/2013 | CN103261411A Hepatitis c virus gene |
08/21/2013 | CN103261407A Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential |
08/21/2013 | CN103261406A Anti-apoptosis or anti-necrosis induction method |
08/21/2013 | CN103261405A Method for forming cell aggregate |
08/21/2013 | CN103261404A Dry granulated cell culture media |
08/21/2013 | CN103261396A Biomass production |
08/21/2013 | CN103261394A Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same |
08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
08/21/2013 | CN103260631A Methods for increasing isolation yields of cellular products |
08/21/2013 | CN103260399A Business method by preserving genes and storing records during lifetime |
08/21/2013 | CN103255168A Construct and application thereof |
08/21/2013 | CN103255164A Construct and use thereof |
08/21/2013 | CN103255149A BGIos040 gene as well as structure and application of gene |